Skip to content

Author

Tian-Yong Li

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Abstract A088: SLC39A6-targeted combination therapy to reverse CAF-induced resistance in HER2+ breast cancer using a microfluidic platform

HER2+ breast cancer accounts for 15–20% of invasive breast cancers, and although eight FDA-approved agents, including monoclonal antibodies, tyrosine-kinase inhibitors, and antibody-drug conjugates, have substantially improved patient survival, resistance in the advanced disease setting remains a significant unmet cl...

Zeina S. Habli, Tian-Yong Li, Mathew Poskus et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.